Home›Clinical trials›The Impact of GLP Medication on Colonoscopy Bowel Preparation Quality

A study listed on ClinicalTrials.gov.

Recruiting now. Registry record last updated December 4, 2025.

Who can join
Adults 18+.
What you take
Check ClinicalTrials.gov for this trial's study groups and what each group receives.
How long it lasts
The study runs about 12 months.
What you get
Costs vary by study. Ask the study team what this one covers, including the study medicine, visits and travel, before you sign the consent form.
This one may not fit you. We check your age, where you live, and the rules each study sets, then show the clinical trials that do.
Check my fit →
Phase Phase 4Sponsor The Cleveland ClinicDrug Continue GLP/GIPClass OtherSites 3 USEnrollment target 132

What this study is for

Primary condition: GLP - 1. Also studied in: Bowel Preparation for Colonoscopy.

Full scientific study title: The Impact of GLP Medication on Colonoscopy Bowel Preparation Quality.

Who can join

Age18 and upSexAny

Adults 18+. A site coordinator confirms whether you qualify during a free screening visit. The exact medical requirements are below.

Full medical eligibility (for you and your doctor)verbatim from the registry

This is the exact wording from ClinicalTrials.gov, including clinical measures (lab values, imaging scores). Bring it to your doctor if any of it is unclear.

Key inclusion criteria

  • Adult patient (Age 18 years or older)
  • Patient scheduled for outpatient screening, surveillance, or diagnostic colonoscopy
  • Using a GLP-1 or GIP agonist at a stable dose for at least one month

Key exclusion criteria

  • Unable to provide informed consent, e.g., dementia
  • Patient refuses the USMSTF recommended bowel cleansing regimen for patients with diabetes or obesity (split-dose 4 liters polyethylene glycol + 15 mg bisacodyl the afternoon before; low residue diet 3 days before colonoscopy; clear liquid diet the day before colonoscopy)
  • Risk factors for inadequate bowel preparation besides diabetes and obesity with a likelihood ratio of 1.6 or greater:
  • Cirrhosis
  • Parkinson's disease

Where this trial is enrolling

This trial has 3 sites across 1 state. Contact a site coordinator directly to start screening.

Florida3 sites
  • Cleveland Clinic
    Cleveland, Florida
    Samita Garg, M.D.216-444-7000GARGS@ccf.org
  • Cleveland Clinic
    Cleveland, Florida
    Samita Garg, MD216-444-2386GARGS@ccf.org
  • Cleveland Clinic Weston
    Weston, Florida
    Tilak Shah, M.D.877.463.2010SHAHT3@ccf.org

Timeline

Started enrolling: August 1, 2025. Expected completion: August 2026. Last updated on ClinicalTrials.gov: December 4, 2025.

Official source

Every Monday we check this trial against ClinicalTrials.gov, the federal registry for clinical research. Last checked September 4, 2026. Confirm the current status there before you contact a site:

View on ClinicalTrials.gov →

Back to the full directory → or take the matching quiz if you want clinical trials filtered to your conditions and location.

John Samaras, editor of GLP Chart
John Samaras, Founder and EditorI started GLP Chart after overpaying for a GLP-1 myself. Based in Austin, Texas.
About this siteLinkedInContact
Why you can trust GLP Chart. Same scoring framework applied to every program. No paid placements. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.